Close Menu

NEW YORK — Cancer Research UK said on Monday that it has awarded a Stanford University-led research team $7.4 million to use a new in situ RNA sequencing technology to identify the drivers of brain tumor growth in children.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Sponsored by

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.